Global Intravenous (IV) Solutions Market Research Report 2023

Report ID: 1974685 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Peripheral Parenteral Nutrition
        1.2.3 Total Parenteral Nutrition
    1.3 Market by Application
        1.3.1 Global Intravenous (IV) Solutions Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital & Clinics
        1.3.3 Ambulatory
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Intravenous (IV) Solutions Market Perspective (2017-2028)
    2.2 Intravenous (IV) Solutions Growth Trends by Region
        2.2.1 Intravenous (IV) Solutions Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2017-2022)
        2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2023-2028)
    2.3 Intravenous (IV) Solutions Market Dynamics
        2.3.1 Intravenous (IV) Solutions Industry Trends
        2.3.2 Intravenous (IV) Solutions Market Drivers
        2.3.3 Intravenous (IV) Solutions Market Challenges
        2.3.4 Intravenous (IV) Solutions Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Intravenous (IV) Solutions Players by Revenue
        3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2017-2022)
        3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2017-2022)
    3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
    3.4 Global Intravenous (IV) Solutions Market Concentration Ratio
        3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2021
    3.5 Intravenous (IV) Solutions Key Players Head office and Area Served
    3.6 Key Players Intravenous (IV) Solutions Product Solution and Service
    3.7 Date of Enter into Intravenous (IV) Solutions Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Solutions Breakdown Data by Type
    4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2017-2022)
    4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2023-2028)
5 Intravenous (IV) Solutions Breakdown Data by Application
    5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2017-2022)
    5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Intravenous (IV) Solutions Market Size (2017-2028)
    6.2 North America Intravenous (IV) Solutions Market Size by Country (2017-2022)
    6.3 North America Intravenous (IV) Solutions Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Intravenous (IV) Solutions Market Size (2017-2028)
    7.2 Europe Intravenous (IV) Solutions Market Size by Country (2017-2022)
    7.3 Europe Intravenous (IV) Solutions Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2017-2028)
    8.2 Asia-Pacific Intravenous (IV) Solutions Market Size by Country (2017-2022)
    8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Intravenous (IV) Solutions Market Size (2017-2028)
    9.2 Latin America Intravenous (IV) Solutions Market Size by Country (2017-2022)
    9.3 Latin America Intravenous (IV) Solutions Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2017-2028)
    10.2 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2017-2022)
    10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 ICU Medical Inc. (U.S.)
        11.1.1 ICU Medical Inc. (U.S.) Company Detail
        11.1.2 ICU Medical Inc. (U.S.) Business Overview
        11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction
        11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.1.5 ICU Medical Inc. (U.S.) Recent Development
    11.2 B. Braun Melsungen AG (Germany)
        11.2.1 B. Braun Melsungen AG (Germany) Company Detail
        11.2.2 B. Braun Melsungen AG (Germany) Business Overview
        11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction
        11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.2.5 B. Braun Melsungen AG (Germany) Recent Development
    11.3 Fresenius Kabi AG (Germany)
        11.3.1 Fresenius Kabi AG (Germany) Company Detail
        11.3.2 Fresenius Kabi AG (Germany) Business Overview
        11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction
        11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.3.5 Fresenius Kabi AG (Germany) Recent Development
    11.4 Baxter (U.S.)
        11.4.1 Baxter (U.S.) Company Detail
        11.4.2 Baxter (U.S.) Business Overview
        11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction
        11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.4.5 Baxter (U.S.) Recent Development
    11.5 Amanta Healthcare (India)
        11.5.1 Amanta Healthcare (India) Company Detail
        11.5.2 Amanta Healthcare (India) Business Overview
        11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction
        11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.5.5 Amanta Healthcare (India) Recent Development
    11.6 Terumo Medical Corporation (Tokyo)
        11.6.1 Terumo Medical Corporation (Tokyo) Company Detail
        11.6.2 Terumo Medical Corporation (Tokyo) Business Overview
        11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction
        11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
    11.7 Grifols S.A. (Spain)
        11.7.1 Grifols S.A. (Spain) Company Detail
        11.7.2 Grifols S.A. (Spain) Business Overview
        11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction
        11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2017-2022)
        11.7.5 Grifols S.A. (Spain) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Peripheral Parenteral Nutrition
    Table 3. Key Players of Total Parenteral Nutrition
    Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Intravenous (IV) Solutions Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Intravenous (IV) Solutions Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Intravenous (IV) Solutions Market Share by Region (2017-2022)
    Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Intravenous (IV) Solutions Market Share by Region (2023-2028)
    Table 10. Intravenous (IV) Solutions Market Trends
    Table 11. Intravenous (IV) Solutions Market Drivers
    Table 12. Intravenous (IV) Solutions Market Challenges
    Table 13. Intravenous (IV) Solutions Market Restraints
    Table 14. Global Intravenous (IV) Solutions Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Intravenous (IV) Solutions Market Share by Players (2017-2022)
    Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2021)
    Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Intravenous (IV) Solutions Product Solution and Service
    Table 21. Date of Enter into Intravenous (IV) Solutions Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Intravenous (IV) Solutions Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2017-2022)
    Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2023-2028)
    Table 27. Global Intravenous (IV) Solutions Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2017-2022)
    Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2023-2028)
    Table 31. North America Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2023-2028) & (US$ Million)
    Table 41. ICU Medical Inc. (U.S.) Company Detail
    Table 42. ICU Medical Inc. (U.S.) Business Overview
    Table 43. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product
    Table 44. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 45. ICU Medical Inc. (U.S.) Recent Development
    Table 46. B. Braun Melsungen AG (Germany) Company Detail
    Table 47. B. Braun Melsungen AG (Germany) Business Overview
    Table 48. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product
    Table 49. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 50. B. Braun Melsungen AG (Germany) Recent Development
    Table 51. Fresenius Kabi AG (Germany) Company Detail
    Table 52. Fresenius Kabi AG (Germany) Business Overview
    Table 53. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product
    Table 54. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 55. Fresenius Kabi AG (Germany) Recent Development
    Table 56. Baxter (U.S.) Company Detail
    Table 57. Baxter (U.S.) Business Overview
    Table 58. Baxter (U.S.) Intravenous (IV) Solutions Product
    Table 59. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 60. Baxter (U.S.) Recent Development
    Table 61. Amanta Healthcare (India) Company Detail
    Table 62. Amanta Healthcare (India) Business Overview
    Table 63. Amanta Healthcare (India) Intravenous (IV) Solutions Product
    Table 64. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 65. Amanta Healthcare (India) Recent Development
    Table 66. Terumo Medical Corporation (Tokyo) Company Detail
    Table 67. Terumo Medical Corporation (Tokyo) Business Overview
    Table 68. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product
    Table 69. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 70. Terumo Medical Corporation (Tokyo) Recent Development
    Table 71. Grifols S.A. (Spain) Company Detail
    Table 72. Grifols S.A. (Spain) Business Overview
    Table 73. Grifols S.A. (Spain) Intravenous (IV) Solutions Product
    Table 74. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2017-2022) & (US$ Million)
    Table 75. Grifols S.A. (Spain) Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Intravenous (IV) Solutions Market Share by Type: 2021 VS 2028
    Figure 2. Peripheral Parenteral Nutrition Features
    Figure 3. Total Parenteral Nutrition Features
    Figure 4. Global Intravenous (IV) Solutions Market Share by Application in 2021 & 2028
    Figure 5. Hospital & Clinics Case Studies
    Figure 6. Ambulatory Case Studies
    Figure 7. Home Care Case Studies
    Figure 8. Intravenous (IV) Solutions Report Years Considered
    Figure 9. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Intravenous (IV) Solutions Market Share by Region: 2021 VS 2028
    Figure 12. Global Intravenous (IV) Solutions Market Share by Players in 2021
    Figure 13. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2021
    Figure 15. North America Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Intravenous (IV) Solutions Market Share by Country (2017-2028)
    Figure 17. United States Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Intravenous (IV) Solutions Market Share by Country (2017-2028)
    Figure 21. Germany Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2017-2028)
    Figure 29. China Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Intravenous (IV) Solutions Market Share by Country (2017-2028)
    Figure 37. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2017-2028)
    Figure 41. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 44. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 45. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 46. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 47. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 48. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 49. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Frequently Asked Questions
Intravenous (IV) Solutions report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intravenous (IV) Solutions report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intravenous (IV) Solutions report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Riveting Tools

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More